No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

Navigate Shifting Reimbursement Criteria for Molecular Testing

Navigate Shifting Reimbursement Criteria for Molecular Testing

At TELCOR, we’ve recently identified a notable shift in how molecular claims specifically associated with CPT code 87798, are being processed by...

Read More
Quality Payment Program Claim Adjustment Applied to Correct Conversion Factor

Quality Payment Program Claim Adjustment Applied to Correct Conversion Factor

The Centers for Medicare & Medicaid Services has found a system issue related to the 2026 Medicare Physician Fee Schedule conversion factors.

Read More
Updated CDLT Data Reporting Period to Begin May 1

Updated CDLT Data Reporting Period to Begin May 1

Effective May 1, clinical diagnostic laboratories will be required to follow new data reporting requirements for clinical diagnostic laboratory tests...

Read More